Metabolic aspects of hepatitis C virus
- PMID: 35979265
- PMCID: PMC9258278
- DOI: 10.3748/wjg.v28.i22.2429
Metabolic aspects of hepatitis C virus
Abstract
Many metabolic factors are associated with chronic hepatitis C virus (HCV) infection and can influence the course of the illness and impact the progression of liver and non-liver-related diseases through complex interactions. Several of these factors impact the course of chronic HCV (CHC) and result in the conceptual translation of CHC from a localized to systemic disease. Besides the traditional liver manifestations associated with CHC infection, such as cirrhosis and hepatocellular carcinoma, various extrahepatic disorders are associated with HCV infection, including atherosclerosis, glucose and lipid metabolic disturbances, alterations in the iron metabolic pathways, and lymphoproliferative diseases. The coexistence of metabolic disorders and CHC is known to influence the chronicity and virulence of HCV and accelerates the progression to liver fibrosis and hepatocellular carcinoma. Insulin resistance is one of the key factors that have a tremendous metabolic impact on CHC. Therefore, there is a great need to properly evaluate patients with CHC infection and correct the modifiable metabolic risk factors. Furthermore, patients with HCV who achieved a sustained virological response showed an overall improvement in glucose metabolism, but the exact evidence still requires further studies with long-term follow-up. This review delineates the most recent evidence on the main metabolic factors associated with CHC and the possible influence of chronic HCV infection on metabolic features.
Keywords: Hepatitis C virus; Insulin resistance; Metabolic factors; Steatosis.
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Figures
Similar articles
-
Metabolic complications of hepatitis C virus infection.World J Gastroenterol. 2021 Apr 7;27(13):1267-1282. doi: 10.3748/wjg.v27.i13.1267. World J Gastroenterol. 2021. PMID: 33833481 Free PMC article. Review.
-
Metabolic dysfunction and cancer in HCV: Shared pathways and mutual interactions.J Hepatol. 2022 Jul;77(1):219-236. doi: 10.1016/j.jhep.2022.01.029. Epub 2022 Feb 12. J Hepatol. 2022. PMID: 35157957 Review.
-
[Type 2 diabetes mellitus, insulin resistance and hepatocellular carcinoma in chronic hepatitis C patients. Data from Northeastern Hungary].Orv Hetil. 2019 Oct;160(40):1591-1602. doi: 10.1556/650.2019.31522. Orv Hetil. 2019. PMID: 31565976 Hungarian.
-
Chronic hepatitis c genotype-4 infection: role of insulin resistance in hepatocellular carcinoma.Virol J. 2011 Nov 1;8:496. doi: 10.1186/1743-422X-8-496. Virol J. 2011. PMID: 22044490 Free PMC article.
-
Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C.Am J Gastroenterol. 2000 Nov;95(11):3211-7. doi: 10.1111/j.1572-0241.2000.03294.x. Am J Gastroenterol. 2000. PMID: 11095344
Cited by
-
Seropositive for hepatitis B and C viruses is associated with the risk of decreased bone mineral density in adults: An analysis of studies from the NHANES database.Front Med (Lausanne). 2023 Mar 22;10:1120083. doi: 10.3389/fmed.2023.1120083. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37035336 Free PMC article.
-
Extrahepatic Manifestations of Chronic Hepatitis C Virus: Review of the Literature.Maedica (Bucur). 2024 Jun;19(2):365-372. doi: 10.26574/maedica.2024.19.2.365. Maedica (Bucur). 2024. PMID: 39188829 Free PMC article. Review.
-
Discovery of Terpenes as Novel HCV NS5B Polymerase Inhibitors via Molecular Docking.Pathogens. 2023 Jun 18;12(6):842. doi: 10.3390/pathogens12060842. Pathogens. 2023. PMID: 37375532 Free PMC article.
References
-
- Lavanchy D. The global burden of hepatitis C. Liver Int. 2009;29 Suppl 1:74–81. - PubMed
-
- Fabrizi F, Donato FM, Messa P. Hepatitis C and Its Metabolic Complications in Kidney Disease. Ann Hepatol. 2017;16:851–861. - PubMed
-
- Younossi Z, Park H, Henry L, Adeyemi A, Stepanova M. Extrahepatic Manifestations of Hepatitis C: A Meta-analysis of Prevalence, Quality of Life, and Economic Burden. Gastroenterology. 2016;150:1599–1608. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical